fluorouracil has been researched along with thymopentin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ameglio, F; Di Lauro, L; Gandolfo, G; Gionfra, T; Lopez, M; Paoletti, G | 1 |
| Fowler, WC; Gerçel-Taylor, C; Taylor, DD; Weese, JL | 1 |
| Ameglio, F; Di Lauro, L; Frasca, AM; Gandolfo, GM; Garaci, E; Lopez, M; Paoletti, G; Rasi, G; Santini, S; Vitelli, G | 1 |
| Li, T; Li, ZW; Wen, HC | 1 |
3 trial(s) available for fluorouracil and thymopentin
| Article | Year |
|---|---|
Thymopentin and interleukin-2 in combination with 5-fluorouracil and leucovorin in metastatic colorectal adenocarcinoma: preliminary results.
Topics: Adenocarcinoma; Colorectal Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Humans; Interleukin-2; Leucovorin; Liver Neoplasms; Male; Middle Aged; Thymopentin | 1991 |
Sequential biochemotherapy for metastatic colorectal cancer using fluorouracil, folinic acid, thymopentin and interleukin-2: clinical and immunological effects.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; Humans; Interferon-gamma; Interleukin-2; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Receptors, Interleukin-2; T-Lymphocyte Subsets; Thymopentin | 1995 |
[Study on the efficacy and safety of high dose thymopentin combined with trans-artery chemoembolization for primary liver cancer].
Topics: Adjuvants, Immunologic; Adult; Aged; Asthenia; CD4-Positive T-Lymphocytes; Chemoembolization, Therapeutic; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Fever; Fluorouracil; Humans; Iodized Oil; Liver Neoplasms; Lymphocyte Count; Male; Middle Aged; Nausea; Organoplatinum Compounds; Oxaliplatin; Remission Induction; Survival Rate; Thymopentin | 2007 |
1 other study(ies) available for fluorouracil and thymopentin
| Article | Year |
|---|---|
Enhancement of antitumor effects of combined chemoimmunotherapy.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; CD4-Positive T-Lymphocytes; Chemotherapy, Adjuvant; Disease Models, Animal; Fluorouracil; Immunotherapy; Levamisole; Lung Neoplasms; Mice; Mice, Inbred C57BL; Pancreatic Neoplasms; Thymopentin | 1993 |